{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:20:55Z","timestamp":1771888855320,"version":"3.50.1"},"reference-count":68,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Colon cancer (CC) is the 3rd most prevalent cancer globally, following breast and lung cancer, with the second-highest mortality rate. Multiple risk factors contribute to CC, and metastasis is the primary cause of increased mortality among CC patients. Natural compounds have been investigated for their ability to concurrently influence various carcinogenic mechanisms by interfering with the expression or activity of their signaling targets. This review focuses on natural flavonoids such as quercetin, taxifolin, and rutin. We discuss how these bioactive compounds potentially mitigate metastasis and associated signaling pathways in colon cancer.<\/p>","DOI":"10.1615\/critrevoncog.2025059214","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:17:53Z","timestamp":1745335073000},"page":"1-10","source":"Crossref","is-referenced-by-count":1,"title":["Review Article: CD151 and TGF-&amp;beta; in Colon Cancer Metastasis: Flavonoids and Their Targeted Delivery Systems"],"prefix":"10.1615","volume":"30","author":[{"given":"Rama Rao","family":"Malla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durga Bhavani","family":"Kundrapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Priyamavada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganji Purnachndra","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y, Chen H, Dai M. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Lett. 2021;522:255-68.","DOI":"10.1016\/j.canlet.2021.09.034"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Shi J, Li Y, Song W, Wang M, Zhang L, Lian H, He Z, Wei N, Zheng Z, Wen J. Risk of colon cancer-related death in people who had cancer in the past. Int J Colorectal Dis. 2022;37(8):1785-97.","DOI":"10.1007\/s00384-022-04202-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: A comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262-74.","DOI":"10.1016\/S2468-1253(21)00426-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713-32.","DOI":"10.1038\/s41575-019-0189-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"O'sullivan DE, Sutherland RL, Town S, Chow K, Fan J, Forbes N, Heitman SJ, Hilsden RJ, Brenner DR. Risk factors for early-onset colorectal cancer: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20(6):1229-40.e1225.","DOI":"10.1016\/j.cgh.2021.01.037"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019;11(1).","DOI":"10.3390\/nu11010164"},{"key":"8","unstructured":"Lotfollahzadeh S, Recio-Boiles A, Cagir B. Colon cancer. Treasure Island, FL: StatPearls; 2023."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Sninsky JA, Shore BM, Lupu GV, Crockett SD. Risk factors for colorectal polyps and cancer. Gastrointest Endosc Clin N Am. 2022;32(2):195-213.","DOI":"10.1016\/j.giec.2021.12.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA. Association of survival with adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803\/Alliance Trial. JAMA Oncol. 2018;4(6):783-90.","DOI":"10.1001\/jamaoncol.2018.0126"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Malki A, Elruz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE. Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int J Mol Sci. 2020;22(1).","DOI":"10.3390\/ijms22010130"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Zhao W, Dai S, Yue L, Xu F, Gu J, Dai X, Qian X. Emerging mechanisms progress of colorectal cancer liver metastasis. Front Endocrinol. 2022;13:081585.","DOI":"10.3389\/fendo.2022.1081585"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Shasha T, Gruijs M, Van Egmond M. Mechanisms of colorectal liver metastasis development. Cell Mol Life Sci. 2022;79(12):607.","DOI":"10.1007\/s00018-022-04630-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Pretzsch E, Bosch F, Neumann J, Ganschow P, Bazhin A, Guba M, Werner J, Angele M. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: Hematogenous versus peritoneal spread. J Oncol. 2019;2019:7407190.","DOI":"10.1155\/2019\/7407190"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Liu M, Fu X, Jiang L, Ma J, Zheng X, Wang S, Guo H, Tian T, Nan K, Wang W. Colon cancer cells secreted CXCL11 via RBP-J\u00ce\u00ba to facilitated tumour-associated macrophage-induced cancer metastasis. J Cell Mol Med. 2021;25(22):10575-90.","DOI":"10.1111\/jcmm.16989"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Li L, Liu J, Xue H, Li C, Liu Q, Zhou Y, Wang T, Wang H, Qian H, Wen T. A TGF-B-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis. Oncogene. 2020;39(10):2125-39.","DOI":"10.1038\/s41388-019-1132-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Pakala SB, Singh K, Reddy SD, Ohshiro K, Li DQ, Mishra L, Kumar R. TGF-B1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene. 2011;30(19):2230-41.","DOI":"10.1038\/onc.2010.608"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Tuncay Cagatay S, Cimen I, Savas B, Banerjee S. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells. Tumour Biol. 2013;34(2):1189-204.","DOI":"10.1007\/s13277-013-0662-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Vu T, Datta PK. Regulation of EMT in colorectal cancer: A culprit in metastasis. Cancers. 2017;9(12):171.","DOI":"10.3390\/cancers9120171"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Sch\u00fcbeler D, Van Nimwegen E, Christofori G. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768-83.","DOI":"10.1016\/j.ccr.2013.04.020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Ca\u00f1ellas A, Hernando-Momblona X, Byrom D, Matarin JA, Calon A, Rivas EI, Nebreda AR, Riera A, Attolini CS, Batlle E. TGF\u00ce\u00b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018;554(7693):538-43.","DOI":"10.1038\/nature25492"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Liu L, Mo M, Chen X, Chao D, Zhang Y, Chen X, Wang Y, Zhang N, He N, Yuan X, Chen H, Yang J. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. J Exp Clin Cancer Res. 2023;42(1):85.","DOI":"10.1186\/s13046-023-02647-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, Satoh S, Kobayashi N, Yamaoka Y, Miyake M. Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. 2003;89(1):158-67.","DOI":"10.1038\/sj.bjc.6601015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kumari S, Devi GT, Badana A, Dasari VR, Malla RR. CD151-A striking marker for cancer therapy. Biomark Cancer. 2015;7:7-11.","DOI":"10.4137\/BIC.S21847"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N, Berditchevski F. Tetraspanin CD151 regulates transforming growth factor beta signaling: Implication in tumor metastasis. Cancer Res. 2010;70(14):6059-70.","DOI":"10.1158\/0008-5472.CAN-09-3497"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Yang T, Wang H, Li M, Yang L, Han Y, Liu C, Zhang B, Wu M, Wang G, Zhang Z, Zhang W, Huang J, Zhang H, Cao T, Chen P, Zhang W. CD151 promotes colorectal cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGF\u00ce\u00b21. Int J Biol Sci. 2021;17(3):848-60.","DOI":"10.7150\/ijbs.53657"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Morgan RG, Mortensson E, Williams AC. Targeting LGR5 in colorectal cancer: Therapeutic gold or too plastic? Br J Cancer. 2018;118(11):1410-8.","DOI":"10.1038\/s41416-018-0118-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Lin PC, Lin SC, Lee CT, Lin YJ, Lee JC. Dynamic change of tetraspanin CD151 membrane protein expression in colorectal cancer patients. Cancer Invest. 2011;29(8):542-7.","DOI":"10.3109\/07357907.2011.606251"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer. 2002;97(3):336-43.","DOI":"10.1002\/ijc.1605"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Erfani S, Hua H, Pan Y, Zhou BP, Yang XH. The context-dependent impact of integrin-associated CD151 and other tetraspanins on cancer development and progression: A class of versatile mediators of cellular function and signaling, tumorigenesis and metastasis. Cancers. 2021;13(9).","DOI":"10.3390\/cancers13092005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yang Y, Yang L, Zhou L, Tang S. A critical review of the effect of dietary fiber intake on the prevention of colorectal cancer in Eastern Asian countries. J Healthc Eng. 2021;2021:6680698.","DOI":"10.1155\/2021\/6680698"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Maiuolo J, Gliozzi M, Carresi C, Musolino V, Oppedisano F, Scarano F, Nucera S, Scicchitano M, Bosco F, Macri R, Ruga S, Cardamone A, Coppoletta A, Mollace A, Cognetti F, Mollace V. Nutraceuticals and cancer: Potential for natural polyphenols. Nutrients. 2021;13(11).","DOI":"10.3390\/nu13113834"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, Al-Mannai S, Therachiyil L, Mir R, Elfaki I, Mir MM, Jamal F, Masoodi T, Uddin S, Singh M, Haris M, Macha M, Bhat AA. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed Pharmacother. 2022;150:113054.","DOI":"10.1016\/j.biopha.2022.113054"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29(3):405-34.","DOI":"10.1007\/s10555-010-9235-2"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting drug chemo-resistance in cancer using natural products. Biomedicines. 2021;9(10).","DOI":"10.3390\/biomedicines9101353"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W, Zheng Q. Natural products as anticancer agents: Current status and future perspectives. Molecules. 2022;27(23).","DOI":"10.3390\/molecules27238367"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244-60.e1216.","DOI":"10.1053\/j.gastro.2014.12.035"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, Rauf A, Aljohani ASM, Simal-Gandara J. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chem Biol Interact. 2022;368:110170.","DOI":"10.1016\/j.cbi.2022.110170"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Liang Z, Xie H, Shen W, Shao L, Zeng L, Huang X, Zhu Q, Zhai X, Li K, Qiu Z, Sui X, Cheng H, Wu Q. The synergism of natural compounds and conventional therapeutics against colorectal cancer progression and metastasis. Front Biosci. 2022;27(9):263.","DOI":"10.31083\/j.fbl2709263"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, Alshabrmi FM, Palai S, Deb PK, Devi R. Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.806470"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Ponte LGS, Pavan ICB, Mancini MCS, Da Silva LGS, Morelli AP, Severino MB, Bezerra RMN, Simabuco FM. The hallmarks of flavonoids in cancer. Molecules. 2021;26(7).","DOI":"10.3390\/molecules26072029"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Bondonno CP, Bondonno NP, Dalgaard F, Murray K, Gardener SL, Martins RN, Rainey-Smith SR, Cassidy A, Lewis JR, Croft KD, Kyro C, Gislason G, Scalbert A, Tjonneland A, Overvad K, Hodgson JM. Flavonoid intake and incident dementia in the Danish Diet, Cancer, and Health cohort. Alzheimers Dement. 2021;7(1):e12175.","DOI":"10.1002\/trc2.12175"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Sethi G, Rath P, Chauhan A, Ranjan A, Choudhary R, Ramniwas S, Sak K, Aggarwal D, Rani I, Tuli HS. Apoptotic mechanisms of Quercetin in liver cancer: Recent trends and advancements. Pharmaceutics. 2023;15(2).","DOI":"10.3390\/pharmaceutics15020712"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Tang SM, Deng XT, Zhou J, Li QP, Ge XX, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604.","DOI":"10.1016\/j.biopha.2019.109604"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Lin R, Piao M, Song Y, Liu C. Quercetin suppresses AOM\/DSS-induced colon carcinogenesis through its anti-inflammation effects in mice. J Immunol Res. 2020;2020:9242601.","DOI":"10.1155\/2020\/9242601"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Han M, Song Y, Zhang X. Quercetin suppresses the migration and invasion in human colon cancer Caco-2 Cells through regulating Toll-like Receptor 4\/Nuclear Factor-kappa B pathway. Pharmacogn Mag. 2016;12(Suppl 2):S237-44.","DOI":"10.4103\/0973-1296.182154"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Nasri Nasrabadi P, Zareian S, Nayeri Z, Salmanipour R, Parsafar S, Gharib E, Asadzadeh Aghdaei H, Zali MR. A detailed image of rutin underlying intracellular signaling pathways in human SW480 colorectal cancer cells based on miRNAs-lncRNAs-mRNAs-TFs interactions. J Cell Physiol. 2019;234(9):15570-80.","DOI":"10.1002\/jcp.28204"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Zhang XA, Zhang S, Yin Q, Zhang J. Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacogn Mag. 2015;11(42):404-9.","DOI":"10.4103\/0973-1296.153096"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Yang L, Liu Y, Wang M, Qian Y, Dong X, Gu H, Wang H, Guo S, Hisamitsu T. Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis. Mol Med Rep. 2016;14(5):4559-66.","DOI":"10.3892\/mmr.2016.5818"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Al-Ghamdi MA, Al-Enazy A, Huwait EA, Albukhari A, Harakeh S, Moselhy SS. Enhancement of Annexin V in response to combination of epigallocatechin gallate and quercetin as a potent arrest the cell cycle of colorectal cancer. Braz J Biol. 2021;83:e248746.","DOI":"10.1590\/1519-6984.248746"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Kang JT, Moon JH, Choi JY, Park SJ, Kim SJ, Saadeldin IM, Lee BC. Effect of antioxidant flavonoids (Quercetin and Taxifolin) on in vitro maturation of porcine oocytes. Asian-Australas J Anim Sci. 2016;29(3):352-8.","DOI":"10.5713\/ajas.15.0341"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Das A, Baidya R, Chakraborty T, Samanta AK, Roy S. Pharmacological basis and new insights of taxifolin: A comprehensive review. Biomed Pharmacother. 2021;142:112004.","DOI":"10.1016\/j.biopha.2021.112004"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Pan B, Xia Y, Gao Z, Zhao G, Wang L, Fang S, Liu L, Yan S. Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt\/ERK signaling pathways. Chin Med. 2022;17(1):36.","DOI":"10.1186\/s13020-022-00588-6"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Razak S, Afsar T, Ullah A, Almajwal A, Alkholief M, Alshamsan A, Jahan S. Taxifolin, a natural flavonoid interacts with cell cycle regulators causes cell cycle arrest and causes tumor regression by activating Wnt\/B-catenin signaling pathway. BMC Cancer. 2018;18(1):1043.","DOI":"10.1186\/s12885-018-4959-4"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Satari A, Ghasemi S, Habtemariam S, Asgharian S, Lorigooini Z. Rutin: A flavonoid as an effective sensitizer for anticancer therapy; insights into multifaceted mechanisms and applicability for combination therapy. Evid Based Complement Alternat Med. 2021;2021:9913179.","DOI":"10.1155\/2021\/9913179"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Li Y, Tang J, Lin Y, Li J, Yang Y, Zhao P, Fei J, Xie Y. Ultrasensitive determination of natural flavonoid rutin using an electrochemical sensor based on metal-organic framework CAU-1\/acidified carbon nanotubes composites. Molecules. 2022;27(22).","DOI":"10.3390\/molecules27227761"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Nouri Z, Fakhri S, Nouri K, Wallace CE, Farzaei MH, Bishayee A. Targeting multiple signaling pathways in cancer: The rutin therapeutic approach. Cancers. 2020;12(8).","DOI":"10.3390\/cancers12082276"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Ben Sghaier M, Pagano A, Mousslim M, Ammari Y, Kovacic H, Luis J. Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells. Biomed Pharmacother. 2016;84:1972-8.","DOI":"10.1016\/j.biopha.2016.11.001"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Zhao X, Deng Y, Xue X, Liao L, Zhou M, Peng C, Li Y. Research progress of Quercetin delivery systems. Curr Pharm Des. 2022;28(9):727-42.","DOI":"10.2174\/1381612828666220317141923"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Attar ES, Chaudhari VH, Deokar CG, Dyawanapelly S, Devarajan PV. Nano drug delivery strategies for an oral bioenhanced quercetin formulation. Eur J Drug Metab Pharmacokinet. 2023;48(5):495-514.","DOI":"10.1007\/s13318-023-00843-7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Riva A, Ronchi M, Petrangolini G, Bosisio S, Allegrini P. Improved oral absorption of Quercetin from Quercetin Phytosome, a new delivery system based on food grade lecithin. Eur J Drug Metab Pharmacokinet. 2019;44(2):169-77.","DOI":"10.1007\/s13318-018-0517-3"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Vinayak M, Maurya AK. Quercetin loaded nanoparticles in targeting cancer: Recent development. Anticancer Agents Med Chem. 2019;19(13):1560-76.","DOI":"10.2174\/1871520619666190705150214"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Xu G, Shi H, Ren L, Gou H, Gong D, Gao X, Huang N. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomed. 2015; 10:2051-63.","DOI":"10.2147\/IJN.S75550"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Sun D, Zou Y, Song L, Han S, Yang H, Chu D, Dai Y, Ma J, O'driscoll CM, Yu Z, Guo J. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B. 2022;12(1):378-93.","DOI":"10.1016\/j.apsb.2021.06.005"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Colpan RD, Erdemir A. Co-delivery of quercetin and caffeic-acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells. J Microencapsul. 2021;38(6):381-93.","DOI":"10.1080\/02652048.2021.1948623"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang H, Cui H, Zhang F, Zhao L, Liu Y, Meng Q. Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers. Drug Deliv. 2022;29(1):342-50.","DOI":"10.1080\/10717544.2022.2027573"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Jain S, Lenaghan S, Dia V, Zhong Q. Co-delivery of curcumin and quercetin in shellac nanocapsules for the synergistic antioxidant properties and cytotoxicity against colon cancer cells. Food Chem. 2023;428:136744.","DOI":"10.1016\/j.foodchem.2023.136744"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Asfour MH, Mohsen AM. Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line. J Adv Res. 2018;9:17-26.","DOI":"10.1016\/j.jare.2017.10.003"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Ismail A, El-Biyally E, Sakran W. An innovative approach for formulation of rutin tablets targeted for colon cancer treatment. AAPS PharmSciTech. 2023;24(2):68.","DOI":"10.1208\/s12249-023-02518-7"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/559681380e010c7e\/CRO-59214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:33:55Z","timestamp":1763620435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,40052c1046b3fad2,559681380e010c7e.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025059214","relation":{},"ISSN":["0893-9675"],"issn-type":[{"value":"0893-9675","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}